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Purpose. The pathogenesis of pseudoexfoliation (PEX), the most common cause of secondary glaucoma, has not been clearly
identified, but there is increasing evidence that points out the role of oxidative stress.The aim of this study is to evaluate some of the
most commonly used blood parameters, hemoglobin (Hb), red blood cell count (RBC), alanine aminotransferase (ALT), and uric
acid (UA) levels, in subjects with PEX.Materials and Methods. This study is performed in a state hospital between November 2011
and December 2012. Retrospective chart review of subjects who underwent cataract surgery was performed. Thirty-one healthy
subjects with PEX and 34 healthy subjects without PEX were evaluated. Hb, RBC, ALT, and UA levels were recorded. Student’s
t-test was used to compare the two groups. Results. The mean age was 73.6 ± 14.1 years in PEX group and 70.1 ± 12.7 in control
group (𝑝 = 0.293). Hb, RBC, ALT, and UA levels did not show a statistically significant difference among PEX and control groups
(𝑝 > 0.05 for all). Conclusion. Serum levels of Hb, RBC, ALT, and UA levels were similar in subjects with and without PEX. Further
studies are needed to clarify the precise role of Hb, RBC, ALT, and UA in the pathogenesis of PEX.
1. Introduction
Pseudoexfoliation (PEX) is a late onset disease with an
increased prevalence by age. Although it is well known by
its ocular features, accumulation of extracellular fibrillar
material in the whole body [1] suggests that PEX is a systemic
disease. In addition to that, PEX was observed to be a
risk factor in systemic diseases such as peripheral vascular
diseases [2], renal arterial stenosis [3], and cardiovascular
diseases [4]. Despite the fact that the pathogenesis of PEX has
not been clearly identified, there is increasing evidence that
points out the role of oxidative stress [5–9].
Uric acid (UA) is the end product of purine metabolism.
Xanthine oxidase (XO) catalyzes the last two reactions:
hypoxanthine +H
2
O +O
2
󴀕󴀬 xanthine +H
2
O
2
xanthine +H
2
O +O
2
󴀕󴀬 uric acid +H
2
O
2
(1)
UA which is one of the most important antioxidants of
plasma [10, 11] has been shown to provide up to %65 of
total plasma antioxidant capacity [12]. UA can be used as a
marker of oxidative stress in hypertension [13] because of the
enzyme,XO,which catalyzes the reactions of hypoxanthine to
xanthine and xanthine to UA and generates one molecule of
hydrogen peroxide in each step. In theory, increased activity
of XO in PEX can cause hyperuricemia [14]. Supporting this
hypothesis, increased adenosine deaminase activity in PEX,
which catalyzes an irreversible reaction in purine catabolism,
can be an additional factor in increment of UA [14]. On the
other hand, increased oxidative stress in PEX might lead to a
decrease in uric acid levels, hypouricemia, because it is one of
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the most important antioxidants of the serum [6, 9]. In both
situations, UA levels may be affected in PEX.
Alanine aminotransferase (ALT) is an enzyme which
represents the hepatocellular injury levels. It catalyzes the
reversible reaction of
L-glutamate + pyruvate 󴀕󴀬 𝛼-ketoglutarate + L-alanine (2)
Besides this feature, ALT was shown to be an independent
marker for oxidative stress [15] and ALT has been reported to
correlate with oxidative stress markers [16].
Most of the parameters used in routine blood tests such
as complete blood count (CBC) and biochemical parameters
have been shown to be related with oxidative stress [15, 17–
20]. Hemoglobin (Hb) is an iron containing metalloprotein
in red blood cells (RBCs) which is used to carry O
2
from the
lungs to the body and CO
2
to lungs from the body. Besides
this main vital function in the body, RBCs and Hb were
reported to reduce the effect of oxidative stress on DNA [17].
All of these parameters mentioned above have a direct or
an indirect relationship with oxidative stress. The aim of this
study is to reveal if there is a relationship among the routine
blood parameters (Hb, RBC, ALT, and UA) and PEX. To the
best of our knowledge these parameters have not been studied
yet.
2. Materials and Methods
The files of patients who underwent cataract surgery in
state hospital between November 2011 and December 2012
were evaluated. Patients with any systemic illness (diabetes,
hypertension, connective tissue diseases, cardiovascular dis-
eases, stroke, autoimmune disease, renal and liver failure,
etc.), drug use, and active smoking were not included in the
study. The presence of any ocular diseases except cataract
and PEX were not included. All of the patients had a record
of complete ophthalmic examination including visual acuity,
Goldmann applanation tonometry, slit lamp biomicroscopic
examination, and dilated anterior and posterior segment
examination. The presence of subjects with and without PEX
was recorded. Subjects who had transillumination defects,
poor dilatation, and peripapillary atrophy were not included
in the study because of the possibility of subtle PEX.Hb, RBC,
ALT, and UA values of the patients were recorded from the
blood tests performed.
Statistical analysis was made by SPSS 17.00 (SPSS Inc.,
Chicago, IL, USA). Continuous variables were expressed as
mean and standard deviation.The Kolmogorov-Smirnov test
was used whether the data distribution were homogeneous.
Age and preoperative laboratory tests among the two groups
were evaluated by independent samples 𝑡-test. Chi-square test
was used for evaluation of the gender status. A 𝑝 value <0.05
was considered statistically significant.
3. Results
There were 31 healthy subjects with PEX and 34 healthy
subjects without PEX. All were Caucasian.There were no age
Table 1: Demographics of pseudoexfoliation and control groups.
PEX group
Mean ± SD
Control group
Mean ± SD 𝑝
Age (years) 73.6 ± 14.1 70.1 ± 12.7 0.293
Sex (male/female) 15/16 17/17 0.920
PEX: pseudoexfoliation; SD: standard deviation.
Table 2: Serum uric acid, alanine aminotransferase, hemoglobin
levels, and red blood cell count of pseudoexfoliation (𝑛 = 31) and
control groups (𝑛 = 34).
Reference
range
PEX group
Mean ± SD
Control group
Mean ± SD 𝑝
Uric acid
(mg/mL) 3.4–7.0 5.27 ± 1.22 5.07 ± 1.54 0.560
ALT (U/L) 1–40 14.15 ± 5.57 13.87 ± 7.48 0.547
HGB (g/dL) 11.5–17.5 13.83 ± 0.67 13.51 ± 0.96 0.346
RBC (M/uL) 3.90–5.50 4.61 ± 0.40 4.56 ± 0.45 0.805
PEX: pseudoexfoliation, SD: standard deviation, HGB: hemoglobin, RBC:
red blood cell count, and ALT: alanine aminotransferase.
and sex differences among the groups. Descriptive values of
groups including age and sex were shown in Table 1.
Although serum levels of Hb, RBC, ALT, and UA were
all higher in PEX group, the difference was not statistically
significant (𝑝 = 0.346, 𝑝 = 0.805, and 𝑝 = 0.547 and 0.560,
resp.). The details were shown in Table 2.
4. Discussion
Oxidative stress can be defined as increased intra/extracellu-
lar concentrations of reactive oxygen species such as superox-
ide anion (O
2
−), hydrogen peroxide (H
2
O
2
), hydroxyl radical
(OH−), peroxyl radical, and singlet oxygen (1O
2
) over the
range of physiologic values. Under normal conditions, ROS
are stabilized by antioxidants which can be divided into two
sections: enzymatic and nonenzymatic. The most common
nonenzymatic antioxidants are glutathione, ascorbic acid,
and uric acid. If the increase in oxidative stress cannot be
balanced by antioxidants, then oxidants can lead to damage
to the lipids (the loss of the integrity of cell membrane),
protein denaturation, and DNA mutations, resulting in cell
death [21]. Various kinds of diseases like aging, cancer devel-
opment, and cardiovascular diseases are related to oxidative
stress [22]. Moreover, ocular diseases like cataract and glau-
coma are associated with oxidative stress [14]. Furthermore,
growing evidence supports the importance of oxidative stress
in PEX [5–9, 14]. Understanding the role of antioxidants in
the development of PEX can provide different approaches for
improved therapeutic intervention and screening.
PEX is a systemic disease in which oxidative stress plays
an important role in the pathogenesis of the disease. Total
antioxidant status [23], antioxidants like ascorbic acid [24] or
methionine [6], trace elements such as zinc [25] or selenium
[26], and antioxidative enzymes such as superoxide dismu-
tase [27] and glutathione peroxidase [27] were all decreased
in PEX syndrome regardless of the samples taken from
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serum, aqueous humor, or tissue. Likewise, XO, a prooxidant
enzyme, has been shown to be increased in serum [14]. On
the other hand, total oxidant status [23] and inhibitors of the
antioxidant enzymes such as asymmetric dimethyl arginine
were increased [28]. In general, antioxidants are decreased
and total oxidant status is increased in PEX.
Uric acid (UA) is one of the most important antioxidants
of plasma [10, 11]. It is the end product of purine nucleotides.
It scavenges reactive oxygen species (ROS) and protects
erythrocyte membrane integrity [29]. It is higher than the
other nonenzymatic antioxidants like ascorbate, glutathione,
tocopherols, and methionine [30]. UA is present in all extra-
cellular spaces like plasma, synovial space, amniotic fluid,
aqueous humor, and the vitreous body [30, 31]. Likewise,
Wayner et al. [12] showed that urate provides up to %65
of total plasma antioxidant capacity. UA level was shown
to be related to cardiovascular diseases [32], hypertension
[33] and diabetes mellitus [34]. Increased UA serum levels in
normotension glaucoma [35], as an indicator of imbalance in
oxidant/antioxidants, have been reported. As far as we know,
this is the first studywhich evaluatesUA in PEX.Therewas no
statistically significant difference found in serumUA levels of
subjects with orwithout PEX (Table 2). Smoking, obesity, and
dietary factors were also reported to alter uric acid levels [36].
Although we checked out smoking in our patients, we did
not determine obesity or dietary factors in our study because
of lack of detailed information in patients’ files. XO, which
produces UA, was reported to be increased in PEX [14]. So an
increased UA level can be expected in PEX. But, on the other
hand, an increased total oxidative stress in PEX can cause a
decrease in UA levels. We think that there may be a balance
in UA. Increased oxidative stress may cause a decrease in UA
which is balanced by UA production by XO.
Although the literature is contradictive, RBCs, especially
Hb in RBCs, may have an effect on DNA repair. Gafter-
Gvili et al. [17] represented that Hb decreased oxidative
stress related DNA damage. Supporting this, Hb protected
lymphocytes against the chromosome breaks caused by
Diepoxybutane, an alkylating agent [37]. On the other hand,
Aksu et al. [38] reported that there was no association
between DNA damage and Hb. Additionally, some authors
have reported contradictory results in whichHb causedDNA
damage in the same fashion of H
2
O
2
[39, 40]. In our study,
although Hb levels and RBCs count were higher in PEX,
these differences were not statistically significant (𝑝 = 0.346,
𝑝 = 0.805).
While we found an increased ALT level in PEX, the dif-
ference was not statistically significant (𝑝 = 0.547). PEX has
been reported to accumulate in liver, but it was not reported
to cause liver dysfunction [1].
Although PEX has been reported with an increased
oxidative stress, we did not find a significant difference in Hb,
RBC, ALT, and UA levels. Because the pathogenesis of PEX
has not been clearly identified, increased oxidative stress and
alterations in antioxidant system do not always necessitate an
alteration of all the enzymes related with oxidative system.
One of the limitations of this study is the design of
the study. This retrospective study can be a pilot study for
upcoming prospective studies. Another limitation is the small
sample size which can affect the results.
In conclusion, UA, ALT, and Hb levels and RBCs count
were not changed in subjects with PEX. Further prospective
studies are needed to clarify the precise role of UA and
antioxidants in the pathogenesis of PEX.
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